Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,268,558 papers from all fields of science
Search
Sign In
Create Free Account
aspartimide
Known as:
2,5-Pyrrolidinedione, 3-amino-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Aspartic Acid
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Structure and Mechanism of an Aspartimide-Dependent Peptide Ligase in Human Legumain**
E. Dall
,
Julia C Fegg
,
P. Briza
,
H. Brandstetter
Angewandte Chemie
2015
Corpus ID: 18062794
Peptide ligases expand the repertoire of genetically encoded protein architectures by synthesizing new peptide bonds…
Expand
Highly Cited
2012
Highly Cited
2012
Convergent solid-phase synthesis of N-glycopeptides facilitated by pseudoprolines at consensus-sequence Ser/Thr residues.
Vera Ullmann
,
Marisa Rädisch
,
+4 authors
C. Unverzagt
Angewandte Chemie
2012
Corpus ID: 42449595
Highly Cited
2012
Highly Cited
2012
Acid-mediated prevention of aspartimide formation in solid phase peptide synthesis.
T. Michels
,
R. Dölling
,
U. Haberkorn
,
W. Mier
Organic Letters
2012
Corpus ID: 21204333
Aspartimide formation is one of the major obstacles that impedes the solid phase synthesis of large peptides and proteins. Until…
Expand
2008
2008
Solid-phase synthesis of cyclic peptide chitinase inhibitors: SAR of the argifin scaffold
Mark J. Dixon
,
Amit Nathubhai
,
O. Andersen
,
D. V. van Aalten
,
I. Eggleston
Organic and biomolecular chemistry
2008
Corpus ID: 12024325
An efficient, all-solid-phase synthesis of argifin, a cyclic peptide chitinase inhibitor with chemotherapeutic potential, is…
Expand
Highly Cited
2007
Highly Cited
2007
Limiting racemization and aspartimide formation in microwave‐enhanced Fmoc solid phase peptide synthesis
Stacey A. Palasek
,
Zachary Cox
,
Jonathan M. Collins
Journal of Peptide Science
2007
Corpus ID: 24494600
Microwave energy represents an efficient manner to accelerate both the deprotection and coupling reactions in 9…
Expand
Highly Cited
2003
Highly Cited
2003
The aspartimide problem in Fmoc‐based SPPS. Part I
M. Mergler
,
F. Dick
,
B. Sax
,
P. Weiler
,
T. Vorherr
Journal of Peptide Science
2003
Corpus ID: 46060970
A variety of Asp β‐carboxy protecting groups, Hmb backbone protection and a range of Fmoc cleavage protocols have been employed…
Expand
Highly Cited
2003
Highly Cited
2003
The aspartimide problem in Fmoc‐based SPPS. Part II
M. Mergler
,
F. Dick
,
B. Sax
,
C. Stähelin
,
T. Vorherr
Journal of Peptide Science
2003
Corpus ID: 5948016
The sequence dependence of base‐catalysed aspartimide formation during Fmoc‐based SPPS was systematically studied employing the…
Expand
Highly Cited
2000
Highly Cited
2000
Peptide thioester preparation by Fmoc solid phase peptide synthesis for use in native chemical ligation
A. Clippingdale
,
C. Barrow
,
J. Wade
Journal of Peptide Science
2000
Corpus ID: 24465330
Established methodology for the preparation of peptide thioesters requires the use of t‐butoxycarbonyl chemistry owing to the…
Expand
Highly Cited
1995
Highly Cited
1995
Sequence dependence of aspartimide formation during 9-fluorenylmethoxycarbonyl solid-phase peptide synthesis
J. Lauer
,
C. Fields
,
G. Fields
Letters in peptide science
1995
Corpus ID: 22797663
We have examined the sequence dependence of aspartimide formation during Fmoc-based solid-phase synthesis of the peptide Val-Lys…
Expand
Highly Cited
1988
Highly Cited
1988
Mechanisms of aspartimide formation: the effects of protecting groups, acid, base, temperature and time.
J. Tam
,
M. W. Riemen
,
R. B. Merrifield
Peptide research
1988
Corpus ID: 20845623
Factors affecting aspartimide formation, such as protecting groups, acidity, basicity, and temperature, were studied using the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE